Delta‐like ligand 4 inhibitor drug treatment induces pulmonary hypertension in cancer clinical trials.
Saved in:
| Title: | Delta‐like ligand 4 inhibitor drug treatment induces pulmonary hypertension in cancer clinical trials. |
|---|---|
| Authors: | Besse, Casandra E.1 (AUTHOR), Winicki, Nolan M.1 (AUTHOR), Puerta, Cristian1 (AUTHOR), Hernandez, Moises1 (AUTHOR), Yuan, Jason X.‐J.2 (AUTHOR), Thistlethwaite, Patricia A.1 (AUTHOR) pthistlethwaite@ucsd.edu |
| Source: | Pulmonary Circulation. Oct2024, Vol. 14 Issue 4, p1-8. 8p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
